| Heading: |
Pancreatic Enzyme Replacement Therapy |
| Question ID: |
1764749 |
| UIN: |
31096 |
| House: |
Commons |
| Date tabled: |
2025-02-12 |
| Asking Member ID: |
4869 |
| Asking Member display name: |
Nadia Whittome
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Nadia Whittome
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the availability of Pancreatic Enzyme Replacement Therapy to all patients who need it. |
| Is named day: |
true |
| Date of holding answer: |
|
| Date answered: |
2025-03-24 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Department continues to engage with all suppliers of pancreatic enzyme replacement therapy (PERT) to boost production to mitigate the supply issue. Increased volumes of PERT are expected for 2025, and specialist importers have sourced unlicensed stock... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |